Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Hypertrophic Cardiomyopathy
Session:
Myocardial and pericardial disease e-posters